J Neuropsychol

1. DECOMBE A, Scarampi C, Malleville E, Capdevielle D, et al
   Non-optimal cognitive offloading in schizophrenia in a prospective memory task: Influence of both metacognitive beliefs and cognitive effort avoidance.
   J Neuropsychol. 2024 Nov 18. doi: 10.1111/jnp.12399.
   

   >> Share

   
   

   
   Mol Psychiatry

2. WEIDENAUER A, Dajic I, Praschak-Rieder N, Willeit M, et al
   The dopaminergic basis of negative symptoms in schizophrenia: an addendum.
   Mol Psychiatry. 2024 Nov 20. doi: 10.1038/s41380-024-02828.
   

   >> Share

   
   
3. CHEN L, Huai C, Song C, Wu S, et al
   Refining antipsychotic treatment strategies in schizophrenia: discovery of genetic biomarkers for enhanced drug response prediction.
   Mol Psychiatry. 2024 Nov 19. doi: 10.1038/s41380-024-02841.
   

   >> Share

   
   

   
   Nature

4. KWON D
   New schizophrenia drug could treat Alzheimer's disease.
   Nature. 2024 Nov 21. doi: 10.1038/d41586-024-03707.
   

   >> Share

   
   

   
   Pharmacopsychiatry

5. FERNANDO P, Strauss J, Wagner E, Lohrs L, et al
   Early Treatment-Resistance in First Episode Psychosis.
   Pharmacopsychiatry. 2024 Nov 15. doi: 10.1055/a-2421-2411.
   

   >> Share

   
   

   
   Proc Natl Acad Sci U S A

6. MU C, Liu P, Liu L, Wang Y, et al
   KCTD10 p.C124W variant contributes to schizophrenia by attenuating LLPS-mediated synapse formation.
   Proc Natl Acad Sci U S A. 2024;121:e2400464121.
   

   >> Share

   
   

   
   Psychiatry Res

7. BERE M, Rossell SL, Toh WL
   Cognition in relation to non-auditory or multisensory hallucinations in schizophrenia-spectrum disorders: A scoping review.
   Psychiatry Res. 2024;342:116268.
   

   >> Share

   
   
8. LAMARCA M, Espinosa V, Acuna V, Vila-Badia R, et al
   Reducing self-stigma in psychosis: A systematic review and meta-analysis of psychological interventions.
   Psychiatry Res. 2024;342:116262.
   

   >> Share

   
   
9. GUTIERREZ G, Garcia de Jalon E, Aranguren L, Corrales A, et al
   Antipsychotic discontinuation in nonaffective first-episode psychosis after clinical remission: Insights from the PEPsNa naturalistic study.
   Psychiatry Res. 2024;342:116261.
   

   >> Share

   
   

   
   Psychol Med

10. ROLDAN L, Sanchez-Gutierrez T, Fernandez-Arias I, Rodriguez-Toscano E, et al
    Cannabis use and cognitive biases in people with first-episode psychosis and their siblings.
    Psychol Med. 2024 Nov 22:1-11. doi: 10.1017/S0033291724001715.
    

    >> Share

    
    
11. YAO G, Luo J, Li J, Feng K, et al
    Functional gradient dysfunction in drug-naive first-episode schizophrenia and its correlation with specific transcriptional patterns and treatment predictions.
    Psychol Med. 2024 Nov 18:1-13. doi: 10.1017/S0033291724001739.
    

    >> Share

    
    
12. HANSEN HG, Speyer H, Sturup AE, Hjorthoj C, et al
    Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial.
    Psychol Med. 2024 Nov 18:1-11. doi: 10.1017/S0033291724002678.
    

    >> Share

    
    
13. ROELL L, Fischer T, Keeser D, Papazov B, et al
    Effects of aerobic exercise on hippocampal formation volume in people with schizophrenia - a systematic review and meta-analysis with original data from a randomized-controlled trial.
    Psychol Med. 2024 Nov 18:1-12. doi: 10.1017/S0033291724001867.
    

    >> Share

    
    
14. YANG J, Liu Z, Pan Y, Fan Z, et al
    Regional neural functional efficiency across schizophrenia, bipolar disorder, and major depressive disorder: a transdiagnostic resting-state fMRI study.
    Psychol Med. 2024 Nov 18:1-12. doi: 10.1017/S0033291724001685.
    

    >> Share

    
    

    
    Schizophr Res

15. LI J, He J, Ren H, Li Z, et al
    Free-water imaging in subcortical gray matter in schizophrenia patients with persistent auditory verbal hallucinations.
    Schizophr Res. 2024;274:517-525.
    

    >> Share

    
    
16. KESHAVAN MS, Seif P, Tandon R
    Muscarinic deficits - part of a cholinergic-dopaminergic- glutamatergic imbalance in schizophrenia?
    Schizophr Res. 2024;274:508-510.
    

    >> Share

    
    
17. CAI H, Shen B, Long JX, Huang XL, et al
    Network analysis of psychotic symptoms in schizophrenia.
    Schizophr Res. 2024;274:501-507.
    

    >> Share

    
    
18. NI P, Ma Y, Chung S
    Mitochondrial dysfunction in psychiatric disorders.
    Schizophr Res. 2024;273:62-77.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share